overview of the final analysis of the phase iii tourmaline-mm1 trial
Published 2 years ago • 124 plays • Length 4:48Download video MP4
Download video MP3
Similar videos
-
2:21
overview of the tourmaline-mm1 study in relapsed/refractory multiple myeloma
-
4:19
final analysis of uvea-ixa study of ixazomib in r/r myeloma
-
2:41
an overview of the latest advances in hematology
-
1:29
initial results of the phase iii boston study
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:33
tourmaline-mm3: undetectable mrd as an endpoint for maintenance therapy
-
11:39
3mensio ct pre-case planning: mitral valve-in-valve tmvr in epic valve
-
29:48
introduction to hematology
-
1:05:36
jeffrey teo - topological phases and universal fractional quasiparticles (tsvp talk at oist)
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
7:58
update on the icaria-mm trial
-
1:33
outcomes of reduced intensity allosct in patients with accelerated-phase myelofibrosis
-
1:36
tourmaline-al1: ixazomib-dexamethasone for al amyloidosis
-
1:59
phase iii trial of imetelstat versus best available therapy in refractory mf
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
2:29
independent prognostic value of total metabolic tumor volume in advanced-stage fl
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:07
update on the lighthouse (op-108) trial
-
1:59
3-year update on the eloquent-2 clinical trial of elotuzumab in multiple myeloma
-
1:35
the impact of frontline maintenance therapy on myeloma patients in the uk